Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1573, 2007-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Switch from tamoxifen to anastrozole benefits QOL in breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :
Access to resources
Recommend
Anastrozole in the management of breast cancer
By Reese David Nabholtz Jean-Marc
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. :
Anastrozole: In Early Breast Cancer
Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. :
Improved QOL with capecitabine in breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. :
5 years' anastrozole superior to tamoxifen in breast cancer
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :